![Stephane Depil](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephane Depil
Keine laufenden Positionen mehr
Profil
Stephane Depil served as the Chief Executive Officer of NETRIS Pharma SAS and as the Medical Director of the Cancer Immunotherapy Program at Centre Léon Bérard Lyon et Rhône-Alpes.
He also worked as the Chief Medical Officer and EVP-Research & Development at Cellectis SA from 2017 to 2019.
Depil holds a doctorate degree from Université de Lille III.
Ehemalige bekannte Positionen von Stephane Depil
| Unternehmen | Position | Ende |
|---|---|---|
| CELLECTIS S.A. | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2019 |
NETRIS Pharma SAS
 NETRIS Pharma SAS BiotechnologyHealth Technology Develops targeted therapies for the treatment of cancer | Vorstandsvorsitzender | - |
Centre Léon Bérard Lyon et Rhône-Alpes | Corporate Officer/Principal | - |
Ausbildung von Stephane Depil
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
5
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Cellectis SA
 Cellectis SA Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops immunotherapies | Health Technology |
Centre Léon Bérard Lyon et Rhône-Alpes | |
Université de Lille III
 Université de Lille III Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NETRIS Pharma SAS
NETRIS Pharma SAS BiotechnologyHealth Technology Develops targeted therapies for the treatment of cancer | Health Technology |
